KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
fibroangioma
¼¶À¯Ç÷°üÁ¾
fibroblast
¼¶À¯¸ð¼¼Æ÷
fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷¼ºÀåÀÎÀÚ
fibroblastic meningioma
¼¶À¯¸ð¼¼Æ÷¼ö¸·Á¾
fibroblastoma
¼¶À¯¸ð¼¼Æ÷Á¾
fibrocalcific
¼¶À¯¼®È¸È-
fibrocartilage
¼¶À¯¿¬°ñ
fibrocartilaginous ring
¼¶À¯¿¬°ñ°í¸®, ¼¶À¯¿¬°ñ·û
fibrocollagenous
¼¶À¯Äݶó°Õ-, ¼¶À¯¾Æ±³-
fibrocystic disease
¼¶À¯³¶º´
fibrocyte
¼¶À¯¼¼Æ÷
fibrodysplasia
¼¶À¯Çü¼ºÀÌ»ó
fibrodysplasia ossificans congenita
¼±Ãµ°ñȼ¶À¯Çü¼ºÀÌ»ó
fibroelastic lamina
¼¶À¯Åº·ÂÆÇ
fibroelastic membrane
¼¶À¯Åº·Â¸·
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
fibroblastic meningioma
¼¶À¯¸ð¼¼Æ÷¼ö¸·Á¾
fibroblastoma
¼¶À¯¸ð¼¼Æ÷Á¾
fibrocartilage
¼¶À¯¿¬°ñ
fibrocartilaginous ring
¼¶À¯¿¬°ñ°í¸®
fibrocystic disease
¼¶À¯³¶º´
fibrocystic dysmucopolysaccharidosis
¼¶À¯³¶ÀÌ»óÁ¡¾×´Ù´çÁúÁõ
fibrocyte
(¢¡fibroblast) ¼¶À¯¸ð¼¼Æ÷
fibrodysplasia
¼¶À¯Çü¼ºÀÌ»ó
fibrodysplasia ossificans congenita
¼±Ãµ°ñȼ¶À¯Çü¼ºÀÌ»ó
fibroelastic lamina
ź·Â¼¶À¯ÆÇ
fibroelastic membrane
¼¶À¯Åº·Â¸·
fibroelastosis
¼¶À¯Åº·Â¼¶À¯Áõ
fibroepithelioma
¼¶À¯»óÇÇÁ¾
fibrofolliculoma
¼¶À¯ÅÐÁýÁ¾
fibrogenesis
¼¶À¯¹ß»ý
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
fibrin-stabilizing factor
¼¶À¯¼Ò ¾ÈÁ¤ÀÎÀÚ, ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ.
fibrinogen
¼¶À¯¼Ò¿ø(¡áÈê«), ÈÀ̺긮³ëÁ¨
fibrinogen
¼¶À¯¼Ò¿ø
fibrinogen consumption test
¼¶À¯¼Ò¿ø ¼Òºñ½ÃÇè(á¼Þ¨ãËúÐ).
fibrinogen degradation products=FDP
¼¶À¯¼Ò¿ø ºÐÇØ»ê¹°
fibrinogenase
¼¶À¯¼Ò¿øÈ¿¼Ò(¡ý£áÈ).
fibrinogenemia
¼¶À¯¼Ò¿øÇ÷Áõ(àéë«áÈê«úìñø).
fibrinoglobulin
¼¶À¯¼Ò±Û·ÎºÒ¸°.
fibrinoid necrosis
¼¶À¯¼Ò¾ç±«»ç
fibrinoid substance
¼¶À¯¼Ò¼º¹°Áú
fibrinokinase
ÈÀ̺긮³ëŰ<³ª>Á¦.
fibrinolysin
¼¶À¯¼Ò¿ëÇØ¼Ò
fibrinolysin
¼¶À¯¼ÒºÐÇØ(¡ÝÂú°).
fibrinolysinemia =fibrinolysinaemia
¼¶À¯¼Ò¿ëÇØ¼Ò, ¼¶À¯¼Ò¿ëÇØ¼ÒÇ÷Áõ .
fibrinolysis
¼¶À¯¼Ò¿ëÇØ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½